Skip to content

A Retrospective Study of Prognostic Factors in Patients with Interstitial Pneumonia Receiving Long-Term Oxygen Therapy

A Retrospective Study of Prognostic Factors in Patients with Interstitial Pneumonia Receiving Long-Term Oxygen Therapy - Prognosis of IP Patients Receiving LTOT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012594
Enrollment
80
Registered
2013-12-17
Start date
2013-12-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial pneumonia

Interventions

None listed

Sponsors

Department of Respiratory Medicine, Allergy, and Rheumatic Diseases Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with clinically diagnosed idioathic interstitial pneumonia or interstitial pneumonia associated with collagen vascular disease who initiated to receive long-term oxygen therapy in Osaka University Hospital from January 1999 to December 2012 were searched. The diagnosis of interstitial pneumonia was determined based on laboratory data, pulmonary function test, physical examination, and high resolution computed tomography findings. The diagnosis of collagen vascular disease was according to established guideline. Long-term oxygen therapy was initiated if PaO2 of arterial blood gas at rest under room air was below 60 mmHg; or if SpO2 on exertion breathing room air was below 90 accompanied by significant dyspnea.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: subjects with interstitial pneumonia suspected to be secondary to environmental exposure or drug toxicities; subjects with severe organ disease or active invasive cancer at the initiation of long-term oxygen therapy.

Design outcomes

Primary

MeasureTime frame
Survival time from the initiation of long-term-oxygen therapy

Countries

Japan

Contacts

Public ContactMasayoshi Higashiguchi

Osaka University Graduate School of Medicine Department of Respiratory Medicine, Allergy and Rheumatic Diseases

higashiguchim@imed3.med.osaka-u.ac.jp06-6879-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026